Erythropoietin and the nervous system / (notice n° 6754)
| 000 -LEADER | |
|---|---|
| fixed length control field | 01506nam a2200217 u 4500 |
| 001 - CONTROL NUMBER | |
| control field | UNI0000315 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20161122165545.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 120419s2005 XX eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0387300104 (hardcover) ($148.00) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780387300108 (hardcover) |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | DCLC |
| 040 ## - CATALOGING SOURCE | |
| Modifying agency | IMIST |
| Description conventions | AFNOR |
| 041 1# - LANGUAGE CODE | |
| Language code of text/sound track or separate title | eng |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 612.8 |
| 245 #0 - TITLE STATEMENT | |
| Title | Erythropoietin and the nervous system / |
| Statement of responsibility, etc | Ahmet Hok |
| 250 ## - EDITION STATEMENT | |
| Edition statement | 1st ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc | [S.l.] |
| Name of publisher, distributor, etc | Springer |
| Date of publication, distribution, etc | 2006. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 223 p. |
| Dimensions | 24 cm. |
| 500 ## - GENERAL NOTE | |
| General note | Erythropoietin (EPO) is a chemokine hormone that is widely distributed throughout the body. In addition to its traditional role as a hormone that stimulates red blood cell production, in recent years many laboratories have shown that EPO can act as a neuroprotective compound in a variety of injury paradigms in the nervous system. Past experience with relatively safety profile of this FDA-approved drug makes it an ideal candidate to take it into clinical trials for neuroprotection. We are on the verge of major clinical trials using this drug for neuroprotection in diseases ranging from stroke, to transverse myelitis to chemotherapy-induced peripheral neuropathy. This is the first book of its kind that brings together researchers from many different disciplines of neuroscience to review the current state-of-the-art in EPO and the nervous system. This book will benefit scientists and clinicians interested in neuroprotection in the broadest sense. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hoke, Ahmet |
| Withdrawn status | Lost status | Damaged status | Not for loan | Permanent Location | Current Location | Date acquired | Inventory number | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| La bibliothèque des Sciences Médicales et Pharmaceutiques | La bibliothèque des Sciences Médicales et Pharmaceutiques | 12157 | 612.8 HOK | 0000000016170 | 11/22/2016 | 11/22/2016 | Livre |
